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Abstract
The view of articular cartilage as a non-regeneration organ has
been challenged in recent years. The articular cartilage consists of
distinct zones with different cellular and molecular phenotypes, and
the superficial zone has been hypothesized to harbour stem cells.
Furthermore, the articular cartilage demonstrates a distinct pattern
regarding stem cell markers (that is, Notch-1, Stro-1, and vascular
cell adhesion molecule-1). These results, in combination with the
positive identification of side population cells in articular cartilage,
give additional support for the hypothesis that articular cartilage
has residing stem cells with a potential regenerative capacity
where the controlling mechanism could be future biomarkers or
drug targets or both.
Articular cartilage has been considered a post-mitotic tissue
with virtually no cellular turnover. This has been based on the
fact that the tissue is hypocellular and avascular and relies on
diffusion for its nutrient supply. In the previous issue of
Arthritis Research & Therapy, Grogan and colleagues [1]
addressed the question of the localization of progenitor cells
in healthy and osteoarthritic (OA) cartilage using Notch-1,
Stro-1, and vascular cell adhesion molecule-1 (VCAM-1) as
markers for stem cells.
Articular cartilage has been proposed to consist of only
terminally differentiated cells in adults, lacking progenitor
cells – a dogma well-established in the textbooks. However,
this dogma has been challenged in recent years [2-4] by the
hypothesis that a progenitor cell population resides in the
superficial zone of the cartilage. An additional challenge to
the dogma is the fact that articular cartilage is not homoge-
nous; instead, biochemical and morphological variations are
seen from the surface zone (SZ) through the middle zone
(MZ) and down to the deep zone (DZ). In the SZ, cells are
flattened and secrete lubricin [5]; in the MZ, the cells are
rounded and arranged in columnar structure and produce
cartilage intermediate layer protein (CILP) [6]; but in the DZ,
the cells are considerably larger and express type X collagen
and alkaline phosphatase.
Grogan and colleagues [1] related their finding to the three
different zones in hyaline cartilage. The authors demonstrated
similar staining patterns for the three makers but with a
distinct zonal distribution pattern in healthy cartilage. The
highest frequencies of stained cells were found in the SZ.
The presence of progenitor cells is a key component to rapid
and successful regeneration of a variety of tissues. The few
studies performed concerning the regenerative potential of
embryonic cartilage are somewhat conflicting. Namba and
colleagues [7] reported that laceration of foetal cartilage has
an intrinsic reparative capacity. On the other hand,
McCullagh and colleagues [8] found no evidence of healing
when transecting the cartilaginous radii of stage 32 embryos
in ovo. For future treatments of cartilage injuries, it is of
interest to ask whether cartilage has the ability to self-repair
and whether this ability is dependent on the presence of
immature progenitor cells.
Studies regarding cartilage development have also shed light
on the question of whether progenitor cells are present in
articular cartilage. There is increasing evidence that articular
cartilage growth during development is achieved by apposition
from the articular surface until puberty [4]. A population of
progenitor cells must then reside within the SZ to provide
transient amplifying progenies for such a mechanism to occur.
Through the use of BrdU (bromo-deoxyuridine) injections, it has
been demonstrated that there are slow-cycling cells, a trait
characteristic of progenitor cells, in the SZ of articular cartilage
[4]. The proposed articular cartilage progenitors have also
been isolated [2]. These cells express the proposed progenitor
marker Notch-1 and possess a high colony-forming efficiency
that was abolished when Notch signalling was blocked [2].
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The surprisingly high numbers of cells positive for stem cell
markers in the paper by Grogan and colleagues [1] could not
possibly correlate to the number of progenitor cells or stem
cells in articular cartilage. To determine stem cell identity, the
authors used a second approach to detect the so-called side
population cells defined by Hoechst dye 33342 which
identifies stem cells by their ability to excrete the dye by the
multi-drug transporter ABCG2. The authors were also able to
demonstrate that the side population had increased chondro-
genic potential compared with non-side population cells.
In OA cartilage, the staining pattern of stem cell markers
differed from that of healthy cartilage, with increased Notch
staining in the MZ as well as increased VCAM-1 staining in the
MZ and DZ. These results are in line with other recent findings
[9]. These markers also differed in staining frequency within
OA clusters, indicating an altered signalling through pathways
important for stem cells. However, no differences in side
population cells were found between healthy and OA cartilage.
The paper by Grogan and colleagues [1] gives a new piece
of evidence of the regenerative potential of articular cartilage.
Human articular chondrocytes are multipotent with a differen-
tiation pattern similar to that of mesenchymal stem cells
[10,11]. Furthermore, the appositional growth of cartilage as
suggested by Dowthwaite and colleagues [2] indicates a
functional role for the superficial layer of cartilage. The
increased activation of Notch-1, Stro-1, VCAM-1, and Sox-9
in OA cartilage could indicate signalling from a regenerative
response in cartilage, and elucidating the signalling pathway
could have bearing on the development of new diagnostic
markers for diseased cartilage and the identification of
potential new drug targets in the future. Additional research is
required in order to determine (a) the location and (b) the
function of the stem cells in human articular cartilage.
Furthermore, the reason for a high number of cells expressing
progenitor markers in articular cartilage needs to be
elucidated. Either the signalling pathways are involved in
metabolic processes unrelated to regenerative processes or
in progenitor cell signalling. The latter, as the authors state,
could be due to the fact that no ‘rescue team’ of circulating
stem cells will home to and repair the damaged cartilage as is
the case in vascularized wound areas and therefore the
number of progenitor cells has to be higher in articular
cartilage compared with other tissues.
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